Adults 18 to 70, any sex, with Visual Acuity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Visual Range at Phase 1Primary· Approximately 15 minutes post lens fitting
Visual range is defined as the log relative energy of simulated haze needed to obscure an otherwise high contrast grating target. Better visual range is indicated by a higher log-relative energy (LRE) of simulated haze (more haze) to obscure an otherwise highly visible target.
Group
Value
95% CI
Senofilcon A (Test) Sphere Strata - Phase 1
3.232
± 0.1658
Senofilcon A (Control) Sphere Strata - Phase 1
3.049
± 0.2101
Senofilcon A (Test) Multifocal Strata - Phase 1
3.287
± 0.1824
Senofilcon A (Control) Multifocal Strata - Phase 1
3.167
± 0.1072
Visual Range at Phase 2Primary· Approximately 15 minutes post lens fitting
Visual range is defined as the log relative energy of simulated haze needed to obscure an otherwise high contrast grating target. Better visual range is indicated by a higher log-relative energy (LRE) of simulated haze (more haze) to obscure an otherwise highly visible target.
Group
Value
95% CI
Senofilcon A (Test) Sphere Strata - Phase 2
3.377
± 0.1489
Senofilcon A (Control) Sphere Strata - Phase 2
3.156
± 0.1181
Senofilcon A (Test) Multifocal Strata - Phase 2
3.181
± 0.1649
Senofilcon A (Control) Multifocal Strata - Phase 2
3.020
± 0.1412
Motion Detection at Phase 1Primary· Approximately 15 minutes post lens fitting
Motion detection is defined as the distance needed (in mm) to determine that a test light has moved from a standard position. Better motion detection is indicated by a smaller distance needed to detect that movement has occurred.
Group
Value
95% CI
Senofilcon A (Test) Sphere Strata - Phase 1
1.725
± 1.3575
Senofilcon A (Control) Sphere Strata - Phase 1
2.881
± 1.9824
Senofilcon A (Test) Multifocal Strata - Phase 1
3.229
± 2.3248
Senofilcon A (Control) Multifocal Strata - Phase 1
2.716
± 3.1286
Brightness Perception at Phase 1Primary· Approximately 15 minutes post lens fitting
Brightness perception is defined as the log- relative energy needed to match a standard stimulus to a natural scene, across 10 different projected scenes. The perception of brighter image is indicated by a higher log-relative energy (LRE) needed to match the initially dim standard to the target.
Group
Value
95% CI
Senofilcon A (Test) Sphere Strata - Phase 1
1.109
± 0.0909
Senofilcon A (Control) Sphere Strata - Phase 1
1.081
± 0.1494
Senofilcon A (Test) Multifocal Strata - Phase 1
1.101
± 0.1388
Senofilcon A (Control) Multifocal Strata - Phase 1
1.041
± 0.2222
Motion Detection at Phase 2Secondary· Approximately 15 minutes post lens fitting
Motion detection is defined as the distance needed (in mm) to determine that a test light has moved from a standard position. Better motion detection is indicated by a smaller distance needed to detect that movement has occurred.
Group
Value
95% CI
Senofilcon A (Test) Sphere Strata - Phase 2
3.894
± 2.6800
Senofilcon A (Control) Sphere Strata - Phase 2
4.288
± 2.9575
Senofilcon A (Test) Multifocal Strata - Phase 2
3.499
± 2.4146
Senofilcon A (Control) Multifocal Strata - Phase 2
3.3376
± 2.3750
Brightness Perception at Phase 2Secondary· Approximately 15 minutes post lens fitting
Brightness perception is defined as the log- relative energy needed to match a standard stimulus to a natural scene, across 10 different projected scenes. The perception of brighter image is indicated by a higher log-relative energy (LRE) needed to match the initially dim standard to the target.
Group
Value
95% CI
Senofilcon A (Test) Sphere Strata - Phase 2
1.356
± 0.0670
Senofilcon A (Control) Sphere Strata - Phase 2
1.222
± 0.0615
Senofilcon A (Test) Multifocal Strata - Phase 2
1.360
± 0.0832
Senofilcon A (Control) Multifocal Strata - Phase 2
1.219
± 0.0843
Sponsor's own description
This is a 2-phase, single-site, non-dispensing, randomized, controlled, double-masked, 2x2 crossover study to objectively measure potential benefits of a new UV/HEV filter using psychophysical testing techniques.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07443215 — Evaluation of Effect of Scatter on Visual Performance
· NA
· recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath
· NA
· active not recruiting
NCT07085533 — Natural History Study of Inherited Retinal Diseases
· recruiting
NCT07135180 — Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups
· NA
· active not recruiting
NCT04632901 — A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
· active not recruiting
Other Johnson & Johnson Vision Care, Inc. trials
Trials by the same sponsor.
NCT07443215 — Evaluation of Effect of Scatter on Visual Performance
· NA
· recruiting
NCT07174596 — Evaluation of Approved Contact Lenses
· NA
· completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
· NA
· completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process
· NA
· completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses
· NA
· completed
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 27 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05601544.